These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37515481)

  • 21. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.
    Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J
    BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease Burden of Rotavirus Gastroenteritis in Children Residing in Germany: A Retrospective, Hospital-based Surveillance.
    Kowalzik F; Zepp F; Hoffmann I; Binder H; Lautz D; van Ewijk R; Knuf M; Tenenbaum T; Laass M; Reuter T; Schulze-Rath R; Marron M
    Pediatr Infect Dis J; 2016 Jan; 35(1):97-103. PubMed ID: 26421806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
    Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Matsunaga M; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Study SR
    Hum Vaccin Immunother; 2020 Oct; 16(10):2495-2501. PubMed ID: 32609565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy.
    Gualano MR; Thomas R; Gili R; Scaioli G; Voglino G; Zotti C
    J Infect Public Health; 2018; 11(6):867-872. PubMed ID: 30078657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
    Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.
    Giménez Sánchez F; Nogueira EJ; Sánchez Forte M; Ibáñez Alcalde M; Cobo E; Angulo R; Garrido Fernández P
    Hum Vaccin Immunother; 2016 Apr; 12(4):1035-9. PubMed ID: 26810147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey.
    Gönüllü E; Soysal A; Yıldız İ; Karaböcüoğlu M
    Hum Vaccin Immunother; 2021 Feb; 17(2):510-516. PubMed ID: 32702249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
    Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
    Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine.
    Kawase M; Hoshina T; Yoneda T; Kojiro M; Takahashi Y; Kusuhara K
    J Infect Chemother; 2020 Mar; 26(3):206-210. PubMed ID: 31563335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.
    Fathima P; Jones MA; Moore HC; Blyth CC; Gibbs RA; Snelling TL
    J Epidemiol; 2021 Aug; 31(8):480-486. PubMed ID: 32801278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Leino T; Baum U; Scott P; Ollgren J; Salo H
    Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.
    Hemming M; Räsänen S; Huhti L; Paloniemi M; Salminen M; Vesikari T
    Eur J Pediatr; 2013 Jun; 172(6):739-46. PubMed ID: 23361964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.
    Gosselin V; Généreux M; Gagneur A; Petit G
    Hum Vaccin Immunother; 2016 Oct; 12(10):2572-2579. PubMed ID: 27367155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016.
    Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA
    BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reverse evidence of rotavirus vaccines impact.
    Martinón-Torres F; Aramburo A; Martinón-Torres N; Cebey M; Seoane-Pillado MT; Redondo-Collazo L; Martinón-Sánchez JM
    Hum Vaccin Immunother; 2013 Jun; 9(6):1289-91. PubMed ID: 23836258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotavirus genotypes in Malaysia and universal rotavirus vaccination.
    Lee WS; Lim BT; Chai PF; Kirkwood CD; Lee JK
    Hum Vaccin Immunother; 2012 Oct; 8(10):1401-6. PubMed ID: 23022710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.